HealthEquity, Inc. (NASDAQ:HQY) Receives $96.17 Average PT from Analysts

Shares of HealthEquity, Inc. (NASDAQ:HQY) have received a consensus rating of “Buy” from the eleven analysts that are covering the stock, MarketBeat.com reports. Eleven research analysts have rated the stock with a buy rating. The average twelve-month price objective among brokerages that have covered the stock in the last year is $96.17.

Several analysts recently weighed in on the company. Royal Bank of Canada lifted their price target on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. Barclays lifted their price target on HealthEquity from $84.00 to $104.00 and gave the stock an “overweight” rating in a report on Friday, February 23rd. Barrington Research reissued an “outperform” rating and set a $100.00 price target on shares of HealthEquity in a report on Friday, March 22nd. KeyCorp lifted their price objective on HealthEquity from $85.00 to $95.00 and gave the company an “overweight” rating in a report on Friday, March 22nd. Finally, BTIG Research lifted their price objective on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, March 20th.

Insider Buying and Selling at HealthEquity

In related news, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, CEO Jon Kessler sold 33,765 shares of the firm’s stock in a transaction that occurred on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the sale, the chief executive officer now owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the firm’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $79.29, for a total value of $2,576,925.00. Following the sale, the director now directly owns 32,123 shares of the company’s stock, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. In the last quarter, insiders have sold 71,322 shares of company stock worth $5,682,895. Insiders own 2.70% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in HQY. Cape Investment Advisory Inc. bought a new position in HealthEquity in the fourth quarter worth approximately $27,000. Rise Advisors LLC bought a new position in shares of HealthEquity in the first quarter valued at approximately $28,000. McGlone Suttner Wealth Management Inc. bought a new position in shares of HealthEquity in the fourth quarter valued at approximately $29,000. YHB Investment Advisors Inc. bought a new position in shares of HealthEquity in the first quarter valued at approximately $40,000. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of HealthEquity in the third quarter valued at approximately $41,000. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Down 1.5 %

HQY stock opened at $78.55 on Tuesday. The company has a quick ratio of 4.76, a current ratio of 4.76 and a debt-to-equity ratio of 0.43. The business has a 50 day moving average price of $80.81 and a two-hundred day moving average price of $74.65. The company has a market cap of $6.74 billion, a price-to-earnings ratio of 122.73, a P/E/G ratio of 1.30 and a beta of 0.55. HealthEquity has a twelve month low of $48.86 and a twelve month high of $84.49.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, topping the consensus estimate of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The company had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. Analysts anticipate that HealthEquity will post 2.12 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.